查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1448820

全球儿科药物市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势和预测

Global Pediatric Medicines Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 201 Pages | 商品交期: 最快1-2个工作天内

价格

全球儿科药品市场需求预计将从 2023 年的 52.2 亿美元增至 2032 年的近 88.7 亿美元，2024-2032 年研究期间复合CAGR为 6.07%。

儿科药物是专门为治疗儿童和婴儿而设计和配製的药物製剂。这些药物考虑了年龄、体重和发育阶段，以确保安全性和有效性。儿科製剂可能包括液体、咀嚼锭或特殊包衣丸剂以方便给药。儿科药物的开发对于满足儿童独特的医疗保健需求、提供准确的剂量和适口的配方以提高依从性和整体治疗效果至关重要。

市场动态

人们对儿童保健的日益关注以及对儿科特定医疗需求的认识不断增强，推动了儿科药品市场的发展。儿科人口的增加、儿科药物配方的进步以及解决儿童未满足的医疗需求的措施等因素都有助于市场成长。对儿科药物开发和扩大儿科临床试验的监管激励措施也极大地推动了儿科药物的创新。此外，儿童慢性病的流行以及对适合年龄的配方和剂型的需求也推动了儿科药品市场的发展。针对各种儿科疾病（包括感染、呼吸系统疾病和神经发育障碍）对安全有效药物的需求，进一步推动了儿科医疗保健领域的研究和开发活动。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球儿科药品市场的各个细分市场进行了包容性评估。儿科药品行业的成长和趋势为本研究提供了整体方法。

市场区隔

儿科药品市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

依药物类型

  • 呼吸系统疾病医学
  • 自体免疫疾病医学
  • 心血管医学
  • 胃肠道药物

依疾病类型

  • 呼吸疾病
  • 传染性疾病
  • 中枢神经系统疾病
  • 胃肠道疾病
  • 肿瘤疾病
  • 其他的

依给药途径

  • 口服
  • 专题
  • 注射用
  • 其他的

按配销通路

  • 医院药房
  • 零售药局
  • 网路药局

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲儿科药品市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。儿科药品市场的主要参与者包括诺华公司、葛兰素史克公司、辉瑞公司、默克公司、阿斯特捷利康公司、强生公司、赛诺菲公司、罗氏控股公司、梯瓦製药工业公司、礼来公司、诺和诺德公司、勃林格殷格翰、百时美施贵宝、艾伯维公司等。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：儿科药物 - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按药品类型分類的市场吸引力分析
    • 按疾病类型分類的市场吸引力分析
    • 按给药途径进行的市场吸引力分析
    • 按配销通路分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球儿科药品市场分析：依药品类型

  • 按药物类型概述
  • 历史和预测数据
  • 依药物类型分析
  • 呼吸系统疾病医学
  • 自体免疫疾病医学
  • 心血管医学
  • 胃肠道药物

第 6 章：全球儿科药物市场分析：依疾病类型

  • 依疾病类型概述
  • 历史和预测数据
  • 依疾病类型分析
  • 呼吸疾病
  • 传染性疾病
  • 中枢神经系统疾病
  • 胃肠道疾病
  • 肿瘤疾病
  • 其他的

第 7 章：全球儿科药物市场分析：依给药途径

  • 依给药途径概述
  • 历史和预测数据
  • 依给药途径分析
  • 口服
  • 专题
  • 注射用
  • 其他的

第 8 章：全球儿科药品市场分析：按分销管道

  • 按配销通路分類的概览
  • 历史和预测数据
  • 按配销通路分析
  • 医院药房
  • 零售药局
  • 网路药局

第 9 章：全球儿科药品市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 10 章：儿科药品公司的竞争格局

  • 儿科药品市场竞争
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 11 章：公司简介

  • 公司股份分析
  • 市场集中度
  • Novartis AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • GlaxoSmithKline
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Pfizer Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Merck & Co.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AstraZeneca
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Johnson & Johnson
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Sanofi
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Roche Holding AG
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Teva Pharmaceutical Industries
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Eli Lilly and Company
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Novo Nordisk A/S
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Boehringer Ingelheim
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bristol-Myers Squibb
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • AbbVie Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Others.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112113829

The global demand for Pediatric Medicines Market is presumed to reach the market size of nearly USD 8.87 Billion by 2032 from USD 5.22 Billion in 2023 with a CAGR of 6.07% under the study period 2024 - 2032.

Pediatric medicines are pharmaceutical formulations specifically designed and formulated for treating children and infants. These medicines consider age, weight, and developmental stages to ensure safety and effectiveness. Pediatric formulations may include liquids, chewable tablets, or specially coated pills to facilitate administration. The development of pediatric medicines is crucial for addressing the unique healthcare needs of children, providing accurate dosages and palatable formulations to enhance compliance and overall therapeutic outcomes.

MARKET DYNAMICS

The increasing focus on child healthcare and the growing awareness of pediatric-specific medical needs drives the pediatric medicines market. Factors such as rising pediatric populations, advancements in pediatric medicine formulations, and initiatives to address unmet medical needs in children contribute to market growth. Regulatory incentives for pediatric drug development and expanding pediatric clinical trials also significantly drive innovation in pediatric medicines. Additionally, the prevalence of chronic diseases in children and the demand for age-appropriate formulations and dosage forms boost the pediatric medicines market. The need for safe and effective medications for various pediatric conditions, including infections, respiratory disorders, and neurodevelopmental disorders, further propels research and development activities in the pediatric healthcare sector.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of pediatric medicines. The growth and trends of pediatric medicines industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the pediatric medicines market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type Of Medicine

  • Respiratory Disorder Medicine
  • Autoimmune Disorder Medicine
  • Cardiovascular Medicine
  • Gastrointestinal Medicines

By Type Of Disease

  • Respiratory Diseases
  • Infectious Diseases
  • Cns Diseases
  • Gastrointestinal Diseases
  • Oncological Diseases
  • Others

By Route Of Administration

  • Oral
  • Topical
  • Parenteral
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Pediatric Medicines market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Pediatric Medicines market include Novartis AG, GlaxoSmithKline, Pfizer Inc., Merck & Co., AstraZeneca, Johnson & Johnson, Sanofi, Roche Holding AG, Teva Pharmaceutical Industries, Eli Lilly and Company, Novo Nordisk A/S, Boehringer Ingelheim, Bristol-Myers Squibb, AbbVie Inc., and others. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . PEDIATRIC MEDICINES - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type of Medicine
    • 3.7.2 Market Attractiveness Analysis By Type of Disease
    • 3.7.3 Market Attractiveness Analysis By Route of Administration
    • 3.7.4 Market Attractiveness Analysis By Distribution Channel
    • 3.7.5 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY TYPE OF MEDICINE

  • 5.1 Overview by Type of Medicine
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type of Medicine
  • 5.4 Respiratory Disorder Medicine Historic and Forecast Sales by Regions
  • 5.5 Autoimmune Disorder Medicine Historic and Forecast Sales by Regions
  • 5.6 Cardiovascular Medicine Historic and Forecast Sales by Regions
  • 5.7 Gastrointestinal Medicines Historic and Forecast Sales by Regions

6 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY TYPE OF DISEASE

  • 6.1 Overview by Type of Disease
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Type of Disease
  • 6.4 Respiratory Diseases Historic and Forecast Sales by Regions
  • 6.5 Infectious Diseases Historic and Forecast Sales by Regions
  • 6.6 CNS Diseases Historic and Forecast Sales by Regions
  • 6.7 Gastrointestinal Diseases Historic and Forecast Sales by Regions
  • 6.8 Oncological Diseases Historic and Forecast Sales by Regions
  • 6.9 Others Historic and Forecast Sales by Regions

7 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY ROUTE OF ADMINISTRATION

  • 7.1 Overview by Route of Administration
  • 7.2 Historical and Forecast Data
  • 7.3 Analysis by Route of Administration
  • 7.4 Oral Historic and Forecast Sales by Regions
  • 7.5 Topical Historic and Forecast Sales by Regions
  • 7.6 Parenteral Historic and Forecast Sales by Regions
  • 7.7 Others Historic and Forecast Sales by Regions

8 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY DISTRIBUTION CHANNEL

  • 8.1 Overview by Distribution Channel
  • 8.2 Historical and Forecast Data
  • 8.3 Analysis by Distribution Channel
  • 8.4 Hospital Pharmacies Historic and Forecast Sales by Regions
  • 8.5 Retail Pharmacies Historic and Forecast Sales by Regions
  • 8.6 Online Pharmacies Historic and Forecast Sales by Regions

9 . GLOBAL PEDIATRIC MEDICINES MARKET ANALYSIS BY GEOGRAPHY

  • 9.1. Regional Outlook
  • 9.2. Introduction
  • 9.3. North America Sales Analysis
    • 9.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.3.2. North America By Segment Sales Analysis
    • 9.3.3. North America By Country Sales Analysis
    • 9.3.4. United State Sales Analysis
    • 9.3.5. Canada Sales Analysis
    • 9.3.6. Mexico Sales Analysis
  • 9.4. Europe Sales Analysis
    • 9.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.4.2. Europe by Segment Sales Analysis
    • 9.4.3. Europe by Country Sales Analysis
    • 9.4.4. United Kingdom Sales Analysis
    • 9.4.5. France Sales Analysis
    • 9.4.6. Germany Sales Analysis
    • 9.4.7. Italy Sales Analysis
    • 9.4.8. Russia Sales Analysis
    • 9.4.9. Rest Of Europe Sales Analysis
  • 9.5. Asia Pacific Sales Analysis
    • 9.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.5.2. Asia Pacific by Segment Sales Analysis
    • 9.5.3. Asia Pacific by Country Sales Analysis
    • 9.5.4. China Sales Analysis
    • 9.5.5. India Sales Analysis
    • 9.5.6. Japan Sales Analysis
    • 9.5.7. South Korea Sales Analysis
    • 9.5.8. Australia Sales Analysis
    • 9.5.9. South East Asia Sales Analysis
    • 9.5.10. Rest Of Asia Pacific Sales Analysis
  • 9.6. Latin America Sales Analysis
    • 9.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.6.2. Latin America by Segment Sales Analysis
    • 9.6.3. Latin America by Country Sales Analysis
    • 9.6.4. Brazil Sales Analysis
    • 9.6.5. Argentina Sales Analysis
    • 9.6.6. Peru Sales Analysis
    • 9.6.7. Chile Sales Analysis
    • 9.6.8. Rest of Latin America Sales Analysis
  • 9.7. Middle East & Africa Sales Analysis
    • 9.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 9.7.2. Middle East & Africa by Segment Sales Analysis
    • 9.7.3. Middle East & Africa by Country Sales Analysis
    • 9.7.4. Saudi Arabia Sales Analysis
    • 9.7.5. UAE Sales Analysis
    • 9.7.6. Israel Sales Analysis
    • 9.7.7. South Africa Sales Analysis
    • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE PEDIATRIC MEDICINES COMPANIES

  • 10.1. Pediatric Medicines Market Competition
  • 10.2. Partnership/Collaboration/Agreement
  • 10.3. Merger And Acquisitions
  • 10.4. New Product Launch
  • 10.5. Other Developments

11 . COMPANY PROFILES OF PEDIATRIC MEDICINES INDUSTRY

  • 11.1. Company Share Analysis
  • 11.2. Market Concentration Rate
  • 11.3. Novartis AG
    • 11.3.1. Company Overview
    • 11.3.2. Company Revenue
    • 11.3.3. Products
    • 11.3.4. Recent Developments
  • 11.4. GlaxoSmithKline
    • 11.4.1. Company Overview
    • 11.4.2. Company Revenue
    • 11.4.3. Products
    • 11.4.4. Recent Developments
  • 11.5. Pfizer Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Revenue
    • 11.5.3. Products
    • 11.5.4. Recent Developments
  • 11.6. Merck & Co.
    • 11.6.1. Company Overview
    • 11.6.2. Company Revenue
    • 11.6.3. Products
    • 11.6.4. Recent Developments
  • 11.7. AstraZeneca
    • 11.7.1. Company Overview
    • 11.7.2. Company Revenue
    • 11.7.3. Products
    • 11.7.4. Recent Developments
  • 11.8. Johnson & Johnson
    • 11.8.1. Company Overview
    • 11.8.2. Company Revenue
    • 11.8.3. Products
    • 11.8.4. Recent Developments
  • 11.9. Sanofi
    • 11.9.1. Company Overview
    • 11.9.2. Company Revenue
    • 11.9.3. Products
    • 11.9.4. Recent Developments
  • 11.10. Roche Holding AG
    • 11.10.1. Company Overview
    • 11.10.2. Company Revenue
    • 11.10.3. Products
    • 11.10.4. Recent Developments
  • 11.11. Teva Pharmaceutical Industries
    • 11.11.1. Company Overview
    • 11.11.2. Company Revenue
    • 11.11.3. Products
    • 11.11.4. Recent Developments
  • 11.12. Eli Lilly and Company
    • 11.12.1. Company Overview
    • 11.12.2. Company Revenue
    • 11.12.3. Products
    • 11.12.4. Recent Developments
  • 11.13. Novo Nordisk A/S
    • 11.13.1. Company Overview
    • 11.13.2. Company Revenue
    • 11.13.3. Products
    • 11.13.4. Recent Developments
  • 11.14. Boehringer Ingelheim
    • 11.14.1. Company Overview
    • 11.14.2. Company Revenue
    • 11.14.3. Products
    • 11.14.4. Recent Developments
  • 11.15. Bristol-Myers Squibb
    • 11.15.1. Company Overview
    • 11.15.2. Company Revenue
    • 11.15.3. Products
    • 11.15.4. Recent Developments
  • 11.16. AbbVie Inc.
    • 11.16.1. Company Overview
    • 11.16.2. Company Revenue
    • 11.16.3. Products
    • 11.16.4. Recent Developments
  • 11.17. Others.
    • 11.17.1. Company Overview
    • 11.17.2. Company Revenue
    • 11.17.3. Products
    • 11.17.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type of Medicine (USD MN)
  • Respiratory Disorder Medicine Market Sales by Geography (USD MN)
  • Autoimmune Disorder Medicine Market Sales by Geography (USD MN)
  • Cardiovascular Medicine Market Sales by Geography (USD MN)
  • Gastrointestinal Medicines Market Sales by Geography (USD MN)
  • Analysis Market by Type of Disease (USD MN)
  • Respiratory Diseases Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • CNS Diseases Market Sales by Geography (USD MN)
  • Gastrointestinal Diseases Market Sales by Geography (USD MN)
  • Oncological Diseases Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Topical Market Sales by Geography (USD MN)
  • Parenteral Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Pediatric Medicines Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Pediatric Medicines Report
  • Market Research Process
  • Market Research Methodology
  • Global Pediatric Medicines Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type of Medicine
  • Market Attractiveness Analysis by Type of Disease
  • Market Attractiveness Analysis by Route of Administration
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type of Medicine (USD MN)
  • Respiratory Disorder Medicine Market Sales by Geography (USD MN)
  • Autoimmune Disorder Medicine Market Sales by Geography (USD MN)
  • Cardiovascular Medicine Market Sales by Geography (USD MN)
  • Gastrointestinal Medicines Market Sales by Geography (USD MN)
  • Global Market Analysis by Type of Disease (USD MN)
  • Respiratory Diseases Market Sales by Geography (USD MN)
  • Infectious Diseases Market Sales by Geography (USD MN)
  • CNS Diseases Market Sales by Geography (USD MN)
  • Gastrointestinal Diseases Market Sales by Geography (USD MN)
  • Oncological Diseases Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Route of Administration (USD MN)
  • Oral Market Sales by Geography (USD MN)
  • Topical Market Sales by Geography (USD MN)
  • Parenteral Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Analysis by Distribution Channel (USD MN)
  • Hospital Pharmacies Market Sales by Geography (USD MN)
  • Retail Pharmacies Market Sales by Geography (USD MN)
  • Online Pharmacies Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Company Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.